Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justine E Roderick

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|April 11, 2019
NOTCH Signaling in T-Cell-Mediated Anti-Tumor Immunity and T-Cell-Based ImmunotherapiesMichelle A Kelliher, Justine E Roderick
Cancer Cell|March 22, 2014
Leukemia propagating cells Akt upAlejandro Gutierrez, Justine E Roderick, Michelle A Kelliher
Cell Reports|August 30, 2016
Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced TumorigenesisMichael I Carr, Justine E Roderick, Hugh S Gannon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2014
Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosisJustine E Roderick, Nicole Hermance, Matija Zelic, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of miceMichael I Carr, Justine E Roderick, Hong Zhang, et al.
The Journal of Clinical Investigation|April 18, 2018
RIP kinase 1-dependent endothelial necroptosis underlies systemic inflammatory response syndromeMatija Zelic, Justine E Roderick, Joanne A O'Donnell, et al.
Blood|August 10, 2017
RUNX1 is required for oncogenic <i>Myb</i> and <i>Myc</i> enhancer activity in T-cell acute lymphoblastic leukemiaAHyun Choi, Anuradha Illendula, John A Pulikkan, et al.
The Journal of Experimental Medicine|June 5, 2013
Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemiaJustine E Roderick, Gabriela Gonzalez-Perez, Christina Arieta Kuksin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 8, 2017
Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and AutoimmunityJoanne A O'Donnell, Jesse Lehman, Justine E Roderick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2018
Correction: Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and AutoimmunityJoanne A O'Donnell, Jesse Lehman, Justine E Roderick, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|April 11, 2019
NOTCH Signaling in T-Cell-Mediated Anti-Tumor Immunity and T-Cell-Based ImmunotherapiesMichelle A Kelliher, Justine E Roderick
Cancer Cell|March 22, 2014
Leukemia propagating cells Akt upAlejandro Gutierrez, Justine E Roderick, Michelle A Kelliher
Cell Reports|August 30, 2016
Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced TumorigenesisMichael I Carr, Justine E Roderick, Hugh S Gannon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2014
Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosisJustine E Roderick, Nicole Hermance, Matija Zelic, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of miceMichael I Carr, Justine E Roderick, Hong Zhang, et al.
The Journal of Clinical Investigation|April 18, 2018
RIP kinase 1-dependent endothelial necroptosis underlies systemic inflammatory response syndromeMatija Zelic, Justine E Roderick, Joanne A O'Donnell, et al.
Blood|August 10, 2017
RUNX1 is required for oncogenic <i>Myb</i> and <i>Myc</i> enhancer activity in T-cell acute lymphoblastic leukemiaAHyun Choi, Anuradha Illendula, John A Pulikkan, et al.
The Journal of Experimental Medicine|June 5, 2013
Therapeutic targeting of NOTCH signaling ameliorates immune-mediated bone marrow failure of aplastic anemiaJustine E Roderick, Gabriela Gonzalez-Perez, Christina Arieta Kuksin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 8, 2017
Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and AutoimmunityJoanne A O'Donnell, Jesse Lehman, Justine E Roderick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 14, 2018
Correction: Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and AutoimmunityJoanne A O'Donnell, Jesse Lehman, Justine E Roderick, et al.
Pageof 3